AMP German Cannabis Group receives an import license for medical cannabis

AMP German Cannabis Group Inc. (“AMP”) (CSE:XCX) has received an import license from the Thuringian State Office. The license covers cannabis products for medical purposes. This is an important milestone for the German company and is another sign of the rising importance of the European cannabis market for cannabis producers and investors alike.

AMP German Cannabis Group Inc. (AMP) (CSE: XCX), has announced that the Thuringian State Office for Consumer Protection (TLV) has granted Alternative Medical Products GmbH (AMP Deutschland), a wholly-owned subsidiary of AMP, a license to import cannabis products for medical use in Germany in accordance with Section 72 of the German Medicines Act (AMG). The TLV is responsible for all fundamental matters of consumer protection and its guidelines in the Free State of Thuringia.

The app offers opportunities for cannabis investors to keep up to date with the latest happenings in the cannabis sector. The app curates cannabis news from across the world and distills it to 400 characters or less, helping you remain informed no matter where you are or how much time you have.

Medical cannabis import

The import license offers AMP the possibility to import medical cannabis purchased outside the European Union into Germany. Immediately after importation to Germany, AMP sells cannabis flowers produced in accordance with EU Good Manufacturing Practice (EU GMP) for medical purposes to pharmaceutical wholesalers which then supply the German pharmacies.

AMP’s supply chain is currently undergoing EU GMP testing to ensure that the quality and integrity of medical cannabis are maintained during transport, storage, testing, and distribution. This audit should be successfully completed before the end of the year.

Agreement for purchase

AMP has signed corresponding supply agreements for the purchase of 2,400 kg of EU-GMP-certified medical cannabis annually with two manufacturers, which will come into effect as soon as the manufacturers issue a Health Canada sales license and EU-GMP certification by TLV. AMP has entered into a multi-year distribution agreement with a German pharmaceutical wholesaler for the annual sale of 1,200 kg of EU-GMP-certified medical cannabis. AMP expects to be able to sign further supply agreements and agreements for pharmaceutical distribution before the end of the year.

SEE ALSO  Are asset-backed cryptos the next big thing?

Dr. Stefan Feuerstein, Managing Director of AMP Germany, explains: “The fact that AMP has obtained its import license according to § 72 AMG (German Medicines Act) after a strict test procedure, a decisive step that ensures the unrestricted import of EU-GMP-certified medical cannabis into Germany.

Alex Blodgett, CEO of AMP, adds: “AMP has created all the conditions to be one of the first major importers of medical cannabis to Germany, which is not itself involved in cultivation. In the near future, we intend to conclude further supply agreements with international partners to supply the German growth market with EU-GMP-certified medical cannabis.

About AMP German Cannabis Group Inc.

Germany has permitted the use of medical cannabis since 2017. The medical cannabis programs and the state’s obligation to cover medical prescriptions are still being developed but will be among the most robust and will set the standards for Europe.

The AMP German Cannabis Group is the parent company of several European investment companies whose main focus is on the import of pharmaceutical quality cannabis (EU-GMP) to Germany. Through its AMP EU-GMP German Certification Protocol Program, AMP offers EU-GMP gap analyses and audits, logistics, transport, and other related services for the import of medical cannabis to Germany.

As a first mover, AMP will quickly establish market leadership in Germany due to its proven German and European management team, unique import model and the ability to meet supply requirements through multiple suppliers from different countries that meet the EU-GMP standard.


Primary Sponsors

Karma Koala Podcast

Top Marijuana Blog